Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision Medicine

Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision Medicine

Despite current advancements in chemotherapy, immunotherapy and targeted treatments, the potential for major adverse cardiovascular events, regardless of previous cardiac history, persists. Scoring systems, such as the Heart Failure Association-International Cardio-Oncology Society (HFA-ICOS) risk a...

Full description

Bibliographic Details
Main Authors: Younan Samuel, Aswin Babu, Foteini Karagkouni, Ayden Ismail, Sunyoung Choi, Stergios Boussios
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Current Issues in Molecular Biology
Subjects:
cardiotoxicity
chemotherapy
immunotherapy
targeted therapy
heart failure
cardiovascular disease
Online Access:https://www.mdpi.com/1467-3045/45/10/526

Internet

https://www.mdpi.com/1467-3045/45/10/526

Similar Items